The cold and flu is a viral infectious disease which primarily affects the nose, throat and may also affect the sinuses and larynx. The common symptoms of cold and flu include scratchy eyes, sneezing, coughing, congestion, runny nose and fatigue. The cold and flu viruses are transmitted in the identical way, but affects the human body differently. Both cold and flu are contracted through eyes, mouth or nose when a person already infected by the virus sneezes or coughs near anybody. Moreover, flu or either called as influenza is a highly contagious virus which affects the respiratory system of human body. Flu can be mild to serious illness and can even cause death to older adults, young children and vulnerable people. Along with this, flu also weakens the immune system of human body. With the rise in spread of cold and flu viruses among individuals, several antiviral drugs are present in the market to prevent and treat the disease as early as possible. Further down, the virus flu is especially dangerous for people having certain risk factors such as asthma, heart problems, blood disorder, chronic respiratory condition, diabetes, liver disease, kidney disease, immune system weakened by consuming heavy amount of medications, and morbid obesity. Increasing cases of cold and flu among people across the globe drives the market growth of cold and flu medications during the forecast period of 2017-2025.
Increasing number of patients suffering from cold and influenza virus, especially young children and adults, propels the market growth of these medicines. Further down, rising awareness among people to treat these diseases as early as possible also creates a high demand and huge market opportunity for cold and flu drugs in the coming years. In addition to this, advertisement of such kind of drugs in television and newspapers by the leading pharmaceutical companies also makes the market demanding. Increasing investment in R&D sector by leading drug manufacturers also results in continuous launch of improved and new drug types. Moreover, the easy intake and pleasant taste of oral syrups for treating cold and flu, is a major factor boosting the growth ofcold and flu medications market during the forecast period. In recent days, most of the oral syrups are Over-the-Counter or OTC drugs which do not require doctor’s prescription, and therefore people having cold and flu prefer to treat them with OTC drugs than going to a healthcare professional. Consumption of oral syrups particularly by elderly patients and children, creates a positive impact on the oral syrup segment, and thereby propels the growth of cold and flu medications market.
The cold and flu medications market in report is segmented bydosage types which include oral syrups, pills or tablets and nasal drops. Moreover, on the basis of distribution channel the market has been segmented as supermarkets, drug stores, mass market, and online market.The global cold and flu medications market has been moreover segmented geographically into North America, Europe, Asia-Pacific, Middle East and Africa and Latin America.
Product innovation and high investment made by leading key vendors, thereby enhances the market growth of cold and flu medicines. However, regular intake of such kind of medications may cause some side effects which may hinder the growth of the market over the next eight years.
Some of the major players in the global cold and flu medications market include GlaxoSmithKline PLC, AccuMed Inc., First Boston Pharma, LLC, Bayer Corp. and few others.
Global Cold and Flu Medications Market: By Distribution Channel
Global Cold and Flu Medications Market: By Dosage Type
Global Cold and Flu Medications Market: By Geography